ReviewCurrent diabetes reports2020
Review of Intravenous and Subcutaneous Electronic Glucose Management Systems for Inpatient Glycemic Control.
Review in Current diabetes reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 20 citations in OpenAlex.
- Results From a Randomized Trial of Intensive Glucose Management Using CGM Versus Usual Care in Hospitalized Adults With Type 2 Diabetes: The TIGHT Study.Diabetes care · 2025Trial
- Trial
- The Association Between Glycemic Variability and In-Hospital Mortality in Patients with Chronic Obstructive Pulmonary Disease: A MIMIC-IV Database-Based Retrospective Cohort Study.International journal of chronic obstructive pulmonary disease · 2026Article
- A decade of InsulinAPP: validation using COSMIN and clinical advancements since its initial publication.Diabetology & metabolic syndrome · 2025Article
- Digital Decision Support for Perioperative Care of Patients With Type 2 Diabetes: A Call to Action.JMIR diabetes · 2025Article
- Inpatient Insulin Dosing Calculators.Diabetes spectrum : a publication of the American Diabetes Association · 2025Article
- AI-based diabetes care: risk prediction models and implementation concerns.NPJ digital medicine · 2024Article
- Clinical Decision Support for Glycemic Management Reduces Hospital Length of Stay.Diabetes care · 2022Article
- Electronic Health Record-Based Decision-Making Support in Inpatient Diabetes Management.Current diabetes reports · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThe goal of this review is to summarize current literature on electronic glucose management systems (eGMS) and discuss their benefits and disadvantages in the inpatient setting. RECENT
findingsWe review different versions of commercially available eGMS: Glucommander™ (Glytec, Greenville, SC), EndoTool
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.